359views
By Godson Umejiego, Correspondent USA
The United States Patent and Trademark Office (USPTO) has announced plans for the Patent Trial and Appeal Board (PTAB) to extend the Motion to Amend (MTA) pilot programme. This programme provides additional options for a patent owner who files an MTA in a trial proceeding under the America Invents Act (AIA).
The MTA pilot programme will run until September 16, 2022. The USPTO may extend the programme (with or without modification) on either a temporary or a permanent basis, or may discontinue the program after that date.
The USPTO has presented preliminary results of the MTA pilot programme and continues to track data related to MTAs.
add a comment
